Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2− advanced breast cancer: final overall survival results of MONARCH 3M.P. Goetz, S. Johnston, Jens Huober et al.|Annals of Oncology|2024Cited by 204
Adjuvant Endocrine Therapy for Early Breast Cancer: A Systematic Review of the Evidence for the 2014 Cancer Care Ontario Systemic Therapy GuidelineOrit Freedman, Andrea Eisen|Current Oncology|2015Cited by 41